OXURION Completes Patient Enrollment for Part A of Phase 2 Study Evaluating THR-149 for Treatment of Diabetic Macular Edema (DME)

NEXT STORY
Polyphor Hosting Key Opinion Leader Roundtable on Covid-19: The Need for Novel Therapies for Severe Infections and the Potential Role of Balixafortide, a Selective CXCR4 Antagonist
PREV STORY
BriaCell Therapeutics Corp. Announces Closing of US$27.2 Million Private Placement
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Assembly Biosciences and BeiGene Announce License and Collaboration Agreement in China for Assembly’s Portfolio of Three Clinical-Stage Core Inhibitors for Chronic Hepatitis B Infection

author_avatar
NASDAQ Market News

Key Opinion Leader Management – Global Industry Analysis and Opportunity Assessment by 2026 | Future Market Insights

Valley Cottage, NY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Key opinion leaders (KOLs) are ...

author_avatar
NASDAQ Market News

Global Airway Management Devices Market to Reach US$2.2 Billion by the Year 2027

author_avatar
NASDAQ Market News